421 related articles for article (PubMed ID: 17142033)
21. VEGF receptors are differentially expressed by neuroblastoma cells in culture.
Beierle EA; Dai W; Langham MR; Copeland EM; Chen MK
J Pediatr Surg; 2003 Mar; 38(3):514-21. PubMed ID: 12632379
[TBL] [Abstract][Full Text] [Related]
22. Ethanol stimulates tumor progression and expression of vascular endothelial growth factor in chick embryos.
Gu JW; Bailey AP; Sartin A; Makey I; Brady AL
Cancer; 2005 Jan; 103(2):422-31. PubMed ID: 15597382
[TBL] [Abstract][Full Text] [Related]
23. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
Chai J; Jones MK; Tarnawski AS
FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
[TBL] [Abstract][Full Text] [Related]
24. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers.
Pufe T; Paulsen F; Petersen W; Mentlein R; Tsokos M
J Pathol; 2003 May; 200(1):130-6. PubMed ID: 12692851
[TBL] [Abstract][Full Text] [Related]
25. 8-prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo.
Pepper MS; Hazel SJ; Hümpel M; Schleuning WD
J Cell Physiol; 2004 Apr; 199(1):98-107. PubMed ID: 14978739
[TBL] [Abstract][Full Text] [Related]
26. An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.
Steiner H; Berger AP; Godoy-Tundidor S; Bjartell A; Lilja H; Bartsch G; Hobisch A; Culig Z
Eur J Cancer; 2004 May; 40(7):1066-72. PubMed ID: 15093584
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
28. A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growth.
Ueda Y; Yamagishi T; Samata K; Ikeya H; Hirayama N; Okazaki T; Nishihara S; Arai K; Yamaguchi S; Shibuya M; Nakaike S; Tanaka M
Cancer Chemother Pharmacol; 2004 Jul; 54(1):16-24. PubMed ID: 15064856
[TBL] [Abstract][Full Text] [Related]
29. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I
Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909
[TBL] [Abstract][Full Text] [Related]
30. VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells.
Fons P; Herault JP; Delesque N; Tuyaret J; Bono F; Herbert JM
J Cell Physiol; 2004 Sep; 200(3):351-9. PubMed ID: 15254962
[TBL] [Abstract][Full Text] [Related]
31. Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1-3)IgG inhibits testosterone-stimulated prostate growth in castrated mice.
Lissbrant IF; Hammarsten P; Lissbrant E; Ferrara N; Rudolfsson SH; Bergh A
Prostate; 2004 Jan; 58(1):57-65. PubMed ID: 14673953
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.
He R; Liu B; Yang C; Yang RC; Tobelem G; Han ZC
Cancer Gene Ther; 2003 Dec; 10(12):879-86. PubMed ID: 14712314
[TBL] [Abstract][Full Text] [Related]
33. VEGF expression in adult permanent thyroid cartilage: implications for lack of cartilage ossification.
Pufe T; Mentlein R; Tsokos M; Steven P; Varoga D; Goldring MB; Tillmann BN; Paulsen FP
Bone; 2004 Aug; 35(2):543-52. PubMed ID: 15268907
[TBL] [Abstract][Full Text] [Related]
34. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
35. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
36. Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro.
Baldanzi G; Mitola S; Cutrupi S; Filigheddu N; van Blitterswijk WJ; Sinigaglia F; Bussolino F; Graziani A
Oncogene; 2004 Jun; 23(28):4828-38. PubMed ID: 15122338
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
Straume O; Akslen LA
Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
[TBL] [Abstract][Full Text] [Related]
38. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
[TBL] [Abstract][Full Text] [Related]
39. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells.
Frankenberry KA; Somasundar P; McFadden DW; Vona-Davis LC
Am J Surg; 2004 Nov; 188(5):560-5. PubMed ID: 15546570
[TBL] [Abstract][Full Text] [Related]
40. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro.
Kao YH; Yu CL; Chang LW; Yu HS
Chem Res Toxicol; 2003 Apr; 16(4):460-8. PubMed ID: 12703962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
